![Media Conferre S.A. - Clinical trials and top publications of antithrombotic therapy in 2018 - 2019 - Goudevenos Ioannis Media Conferre S.A. - Clinical trials and top publications of antithrombotic therapy in 2018 - 2019 - Goudevenos Ioannis](https://i.ytimg.com/vi/dTZp-2Aq9RQ/maxresdefault.jpg)
Media Conferre S.A. - Clinical trials and top publications of antithrombotic therapy in 2018 - 2019 - Goudevenos Ioannis
![Media Conferre S.A. - Clinical trials and top publications of antithrombotic therapy in 2018 - 2019 - Goudevenos Ioannis Media Conferre S.A. - Clinical trials and top publications of antithrombotic therapy in 2018 - 2019 - Goudevenos Ioannis](https://media.conferre.gr/media/com_allvideoshare/videos/2019-03/afisa5c9522295aa51.jpg)
Media Conferre S.A. - Clinical trials and top publications of antithrombotic therapy in 2018 - 2019 - Goudevenos Ioannis
![In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Prevalence, - ppt download In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Prevalence, - ppt download](https://slideplayer.com/12696953/77/images/slide_1.jpg)
In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Prevalence, - ppt download
![Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical Trial | Bentham Science Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical Trial | Bentham Science](https://www.eurekaselect.com/images/graphical-abstract/cvp/17/6/009.jpg)
Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical Trial | Bentham Science
![CONTRAINDICATIONS FOR P2Y12 INHIBITORS IN REAL-LIFE PATIENTS WITH ACUTE CORONARY SYNDROME: INSIGHTS FROM THE GREEK ANTIPLATELET (GRAPE) REGISTRY | Journal of the American College of Cardiology CONTRAINDICATIONS FOR P2Y12 INHIBITORS IN REAL-LIFE PATIENTS WITH ACUTE CORONARY SYNDROME: INSIGHTS FROM THE GREEK ANTIPLATELET (GRAPE) REGISTRY | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/c207c9f6-a3c4-4e01-94ef-f659d913278f/s0735-1097(13)60044-3.fp.png)